Bardoxolone methyl breaks the vicious cycle between M1 macrophages and senescent nucleus pulposus cells through the Nrf2/STING/NF-κB pathway - ScienceDirect
Schematic image of potential mechanism by which bardoxolone methyl... | Download Scientific Diagram
Bardoxolone methyl: drug development for diabetic kidney disease | Clinical and Experimental Nephrology
Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites | Journal of Medicinal Chemistry
BARDOXOLONE METHYL
Bardoxolone methyl | C32H43NO4 | CID 400769 - PubChem
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma - ScienceDirect
Bardoxolone methyl (RTA 402) | ≥99%(HPLC) | IκB/IKK inhibitor | AdooQ®
Bardoxolone methyl: drug development for diabetic kidney disease | Clinical and Experimental Nephrology
Bardoxolone conjugation enables targeted protein degradation of BRD4 | Scientific Reports
Bardoxolone in Alport Syndrome: The CARDINAL trial — NephJC
Antioxidants | Free Full-Text | Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls
Frontiers | Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity
NF-κB Signaling | NF-kappaB Pathway
Figure 2 from Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties | Semantic Scholar
Pharmacodynamics of bardoxolone methyl. A, levels of NF- k B, cyclin... | Download Scientific Diagram
Synthesis, Biological Evaluation, and Molecular Docking Study of 3-Amino and 3-Hydroxy-seco A Derivatives of α-Amyrin and 3-Epilupeol as Inhibitors of COX-2 Activity and NF-kB Activation | Journal of Natural Products
Bardoxolone methyl (RTA 402) | Nrf2 Activator | MedChemExpress
NF‐κB signaling in inflammation and cancer - Zhang - 2021 - MedComm - Wiley Online Library
Bardoxolone - an overview | ScienceDirect Topics
Antioxidants | Free Full-Text | Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls
Bardoxolone Methyl | ≥99%(HPLC) | Selleck | IκB/IKK 阻害剤
NF‐κB signaling in inflammation and cancer - Zhang - 2021 - MedComm - Wiley Online Library
Bardoxolone methyl (RTA 402) | Nrf2 Activator | MedChemExpress
Increased albuminuria in bardoxolone methyl–treated type 2 diabetes patients: mere reflection of eGFR improvement? - ScienceDirect
Frontiers | Bardoxolone Methyl Ameliorates Compression-Induced Oxidative Stress Damage of Nucleus Pulposus Cells and Intervertebral Disc Degeneration Ex Vivo
Bardoxolone (CDDO) | Keap1-Nrf2 Activator | MedChemExpress
